Skip to main content
. 2017 Apr 13;8(31):50761–50773. doi: 10.18632/oncotarget.17098

Figure 9. Validation of ZNF503-AS1 based on in-house clinical samples of LUSC.

Figure 9

(A) The expression of ZNF503-AS1 between para-tumorous lung tissues (pT) and LUSC (RT-qPCR); (B) ROC curve; (C) The correlation of ZNF503-AS1 between para-tumorous lung tissues (pT) and LUSC.pT: para-noncancerous tissues.